Reynolds Deborah, Annunziato Rachel A, Sidhu Jasleen, Cotter Gad, Davison Beth A, Takagi Koji, Duncan-Park Sarah, Rubinstein David, Shemesh Eyal
NYC Health + Hospitals/Elmhurst, Queens, New York, NY 11373, USA.
Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY 10029, USA.
J Clin Med. 2024 Oct 21;13(20):6274. doi: 10.3390/jcm13206274.
It has recently been shown that excessive fluctuation in blood pressure readings for an individual over time is closely associated with poor outcomes, including increased risk of cardiovascular mortality, coronary heart disease and stroke. Fluctuations may be associated with inconsistent adherence to medical recommendations. This new marker of risk has not yet been incorporated into a monitoring and intervention strategy that seeks to reduce cardiovascular risk by identifying patients through an algorithm tied to their electronic health record (EHR). We describe the methods used in an innovative "proof of concept" trial using CP&R (Cardiovascular Precision Medicine and Remote Intervention). A blood pressure variability index is calculated for clinic patients via an EHR review. Consenting patients with excessive variability are offered a remote intervention aimed at improving adherence to medical recommendations. The outcomes include the ability to identify and engage the identified patients and the effects of the intervention on blood pressure variability using a pre-post comparison design without parallel controls. Our innovative approach uses a recently identified marker based on reviewing and manipulating EHR data tied to a remote intervention. This design reduces patient burden and supports equitable and targeted resource allocation, utilizing an objective criterion for behavioral risk. This study is registered under ClinicalTrials.gov Identifier: NCT05814562.
最近有研究表明,个体血压读数随时间的过度波动与不良后果密切相关,包括心血管疾病死亡率增加、冠心病和中风风险上升。波动可能与对医疗建议的依从性不一致有关。这种新的风险标志物尚未纳入旨在通过与电子健康记录(EHR)相关的算法识别患者来降低心血管风险的监测和干预策略中。我们描述了在一项使用CP&R(心血管精准医学和远程干预)的创新性“概念验证”试验中所采用的方法。通过EHR审查为门诊患者计算血压变异性指数。为血压变异性过高且同意参与的患者提供旨在提高对医疗建议依从性的远程干预。结果包括识别并促使已识别患者参与干预的能力,以及使用前后比较设计且无平行对照的情况下干预对血压变异性的影响。我们的创新方法基于审查和处理与远程干预相关的EHR数据,使用了最近确定的标志物。这种设计减轻了患者负担,并支持公平且有针对性的资源分配,利用行为风险的客观标准。本研究已在ClinicalTrials.gov上注册,标识符为:NCT05814562。